Received May 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
| TTOX | TETANUS TOXOID (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Experienced sore, tight/stiff arm, and inject site soreness; Experienced sore, tight/stiff arm, and inject site soreness; tight/stiff arm; This spontaneous report was received from a consumer, referring to herself, a 50-year-old female patient. The patient's concomitant drugs included breast cancer medication. The patient's medical history, historical drugs, past drug reactions or allergies, and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with Pneumococcal 21v conj vaccine (CRM197) (CAPVAXIVE) (dose, strength, route of administration, lot#, and expiration date were not reported) for prophylaxis by a Health Professional; together with Tetanus vaccine (dose, strength, route of administration, lot#, and expiration date were not reported). On 29-APR-2025, the patient experienced sore, tight/stiff arm, and inject site soreness. At the time of reporting, the outcome of the events above was unknown. The causal relationship between the events above and the suspected vaccines was not reported. Lot# is being requested and will be submitted if received.